{"title":"全球思维，全球行动:全球中心在肿瘤药物开发中的关键作用","authors":"Joe Woolery","doi":"10.14229/onco.2023.10.03.002","DOIUrl":null,"url":null,"abstract":"When global health crises such as the COVID-19 pandemic and HIV/AIDS epidemic occur, drug developers and researchers have an opportunity to highlight the benefits of implementing international clinical development plans to make treatments available as quickly as possible for patients around the world. However, when these public crises are not a factor, organizations typically wait until a product is nearing its approval stage before planning for and developing an international strategy.","PeriodicalId":496622,"journal":{"name":"Onco'zine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Think Globally, Act Globally: The Key Role Global Hubs Play in Oncological Drug Development\",\"authors\":\"Joe Woolery\",\"doi\":\"10.14229/onco.2023.10.03.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"When global health crises such as the COVID-19 pandemic and HIV/AIDS epidemic occur, drug developers and researchers have an opportunity to highlight the benefits of implementing international clinical development plans to make treatments available as quickly as possible for patients around the world. However, when these public crises are not a factor, organizations typically wait until a product is nearing its approval stage before planning for and developing an international strategy.\",\"PeriodicalId\":496622,\"journal\":{\"name\":\"Onco'zine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Onco'zine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14229/onco.2023.10.03.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Onco'zine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14229/onco.2023.10.03.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Think Globally, Act Globally: The Key Role Global Hubs Play in Oncological Drug Development
When global health crises such as the COVID-19 pandemic and HIV/AIDS epidemic occur, drug developers and researchers have an opportunity to highlight the benefits of implementing international clinical development plans to make treatments available as quickly as possible for patients around the world. However, when these public crises are not a factor, organizations typically wait until a product is nearing its approval stage before planning for and developing an international strategy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
